Supplement Safety Critic Cohen Suggests Stronger, Responsive AER System
This article was originally published in The Tan Sheet
Executive Summary
Pieter Cohen says a “small fraction of what’s going on” with supplement-related adverse events is reported to MedWatch because many physicians as well as consumers are not aware they can report AEs to FDA. He also is critical of FDA and manufacturers’ responsiveness to reports submitted to MedWatch.
You may also be interested in...
DMAA Warnings Shed Light On FDA NDI Enforcement
FDA’s warning letters to 10 marketers of DMAA-containing products might have a silver lining for the supplement industry as they suggest the agency may be flexible on its controversial interpretation of some provisions in the new dietary ingredient notification requirement.
Perrigo Steers Through Transportation Obstacles, Soaring Shipping Costs From COVID-19
Perrigo largely has resolved distribution problems, but shipping freight costs still are much higher than pre-pandemic and it must divest a wound-care brand before US regulators sign off on acquisition of HRA Pharma, says CEO Murray Kessler during J.P. Morgan conference.
In Flip Of Bausch Health’s Planned Order For IPOs, Bausch + Lomb Registration Comes Before Solta
“We are positioned to move forward with either the Bausch + Lomb or Solta IPO quickly when market conditions are right for each of them,” CEO Joseph Papa says at J.P. Morgan conference, but the firm’s “next step” in the process of separating the two businesses was filing with the SEC an IPO registration for Bausch + Lomb.